Literature DB >> 11827073

Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases.

M J Edel1, J M Harvey, J M Papadimitriou.   

Abstract

It is well established that the ability of a neoplasm to induce a blood supply from a pre-existing circulation (angiogenesis) is a major factor in tumour growth, invasion and metastasis. However, the angiogenic potential of metastases and their subsequent growth have not been extensively studied. The question arises: can metastatic clones induce the same level of angiogenesis as in the primary neoplasm they emanated from? In this study it is hypothesised that in the same patient the level of vascularity and angiogenesis is the same in both the primary invasive ductal carcinoma and in the axillary lymph node metastasis at the time of surgery, according to Kerbels theory of clonal-dominance. To directly address the hypothesis, morphological measures of the established blood/lymphatic circulation (vascularity) as well as estimates of angiogenesis (endothelial cell proliferation) were measured in primary tumours and directly compared to the same parameters in the corresponding lymph node metastasis in a case by case basis (n = 17). The results demonstrate varying associations between the level of vascularity and angiogenesis between matched individual tumours and their metastatic lymph nodal deposits. It is possible that either variations in the angiogenic characteristics of the metastasising clone or local or systemic promoters or inhibitors of angiogenesis influence tumour angiogenesis at the different sites.

Entities:  

Mesh:

Year:  2000        PMID: 11827073     DOI: 10.1023/a:1013139022051

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  41 in total

Review 1.  Ki-67 staining as a means to simplify analysis of tumor cell proliferation.

Authors:  C L Hitchcock
Journal:  Am J Clin Pathol       Date:  1991-10       Impact factor: 2.493

Review 2.  Monoclonal antibody Ki-67: its use in histopathology.

Authors:  D C Brown; K C Gatter
Journal:  Histopathology       Date:  1990-12       Impact factor: 5.087

3.  Which proliferation markers for routine immunohistology? A comparison of five antibodies.

Authors:  D S Rose; P H Maddox; D C Brown
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

Review 4.  Growth dominance of the metastatic cancer cell: cellular and molecular aspects.

Authors:  R S Kerbel
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

5.  Assessment of vascularity in breast carcinoma by computer-assisted video analysis (CAVA) and its association with axillary lymph node status.

Authors:  M J Edel; P D Robbins; J M Papadimitriou; M F D'Antuono; J M Harvey; C A Mitchel; H J Dawkins
Journal:  Breast Cancer Res Treat       Date:  1998-01       Impact factor: 4.872

6.  Locally increased metastatic efficiency as a reason for preferential metastasis of solid tumors to lymph nodes.

Authors:  G F Whalen; S F Sharif
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

7.  Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody.

Authors:  C Mazerolles; P Rishmann; D Chopin; Z Popov; B Malavaud; J Selves; I Neulat-Duga; J Bellot; G Delsol
Journal:  Histopathology       Date:  1994-12       Impact factor: 5.087

8.  Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features.

Authors:  S M Veronese; M Gambacorta
Journal:  Am J Clin Pathol       Date:  1991-01       Impact factor: 2.493

9.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

10.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

View more
  6 in total

Review 1.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

2.  Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer.

Authors:  Yan-Feng Xiao; Shan-Xi Liu; De-Dong Wu; Xi Chen; Li-Fen Ren
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

3.  Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.

Authors:  Yan-Feng Xiao; De-Dong Wu; Shan-Xi Liu; Xi Chen; Li-Fen Ren
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

4.  The determination of VEGF and MVD, among patients with primary breast cancer.

Authors:  Anna Thielemann; Zygmunt Kopczyński; Violetta Filas; Jan Breborowicz; Sylwia Grodecka-Gazdecka; Aleksandra Baszczuk
Journal:  Pathol Oncol Res       Date:  2008-04-09       Impact factor: 3.201

5.  Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.

Authors:  G G Van den Eynden; I Van der Auwera; S J Van Laere; C G Colpaert; H Turley; A L Harris; P van Dam; L Y Dirix; P B Vermeulen; E A Van Marck
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

Review 6.  Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment.

Authors:  Nancy Boudreau; Connie Myers
Journal:  Breast Cancer Res       Date:  2003-03-10       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.